THE EFFECT OF INTRAVENOUS GAMMA-GLOBULIN ON THE INDUCTION OF EXPERIMENTAL ANTIPHOSPHOLIPID SYNDROME

被引:87
|
作者
BAKIMER, R
GUILBURD, B
ZURGIL, N
SHOENFELD, Y
机构
[1] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
[2] BEN GURION UNIV NEGEV,FAC HLTH SCI,IL-84105 BEER SHEVA,ISRAEL
来源
关键词
D O I
10.1006/clin.1993.1155
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antiphospholipid syndrome (APLS) is characterized by anti-cardiolipin antibodies (ACA) and/or lupus anticoagulant, recurrent thromboembolic phenomena, thrombocytopenia, and recurrent fetal loss. Recently, we reported on the induction of experimental APLS by passive transfer of ACA to naive mice. In the current study we examined the effect of intravenous γ-globulins (IVGG) on the obstetric complication of experimental APLS. After showing the binding of IVGG to mouse and human ACA (e.g., the existence of natural anti-idiotypic autoantibodies to ACA) we infused 36 μg of IVGG to the tail vein of mice in which experimental APLS was induced by passive transfer of monoclonal mouse ACA (CAR). Mice treated with IVGG had significantly less fetal resorptions when mated, in comparison to untreated mice (5-13 ± 6% vs 25 ± 17%). The best results were achieved when IVGG was given 2 days after induction of the disease (on Day 6 of pregnancy). It seems that IVGG may be employed as a good adjunct to any therapy of APLS. © 1993 by Academic Press, Inc.
引用
收藏
页码:97 / 102
页数:6
相关论文
共 50 条
  • [31] EFFECT OF INTRAVENOUS GAMMA-GLOBULIN (IVIG) ON THE PLATELET COUNT IN PATIENTS WITH WISKOTT-ALDRICH SYNDROME
    MATHEW, P
    CONLEY, ME
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 1995, 6 (02) : 91 - 94
  • [32] BENEFICIAL EFFECT OF HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN IN POST INFECTION FATIGUE SYNDROME
    LLOYD, A
    WAKEFIELD, D
    DWYER, J
    BOUGHTON, C
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 453 - 453
  • [33] DEVELOPMENT OF AN INTRAVENOUS GAMMA-GLOBULIN WITH FC ACTIVITIES .2. RECONVERSION OF S-SULFONATED HUMAN GAMMA-GLOBULIN INTO ORIGINAL GAMMA-GLOBULIN
    MASUHO, Y
    TOMIBE, K
    WATANABE, T
    FUKUMOTO, Y
    VOX SANGUINIS, 1977, 32 (05) : 290 - 295
  • [34] INTRAVENOUS GAMMA-GLOBULIN IN MANAGEMENT OF PATIENTS WITH HYPOGAMMAGLOBULINEMIA
    MAGILAVY, DB
    CASSIDY, JT
    TUBERGEN, DG
    PETTY, RE
    CHISHOLM, R
    MCCALL, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1978, 61 (06) : 378 - 383
  • [35] INTRAVENOUS GAMMA-GLOBULIN FOR ADULT KAWASAKI DISEASE
    CHAVANET, P
    PORTIER, H
    ESCALIER, F
    COURTOIS, B
    LANCET, 1985, 2 (8465): : 1184 - 1185
  • [36] INTRAVENOUS GAMMA-GLOBULIN THERAPY IN IMMUNE THROMBOCYTOPENIA
    KAPLAN, M
    ABRAMOV, A
    GOREN, A
    JOURNAL OF PEDIATRICS, 1988, 112 (03): : 504 - 504
  • [37] INTRAVENOUS GAMMA-GLOBULIN IN THE TREATMENT OF ANGIOIMMUNOBLASTIC LYMPHADENOPATHY
    SELSKY, C
    KIRKPATRICK, D
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 483 - 483
  • [38] HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN
    ATRAH, HI
    CRAWFORD, RJ
    GABRA, GS
    MITCHELL, R
    LANCET, 1985, 1 (8433): : 876 - 876
  • [39] INTRAVENOUS GAMMA-GLOBULIN FOR REACTION TO INTRAMUSCULAR PREPARATION
    PEERLESS, AG
    STIEHM, ER
    LANCET, 1983, 2 (8347): : 461 - 461
  • [40] NEW AND CONTROVERSIAL USES OF INTRAVENOUS GAMMA-GLOBULIN
    PAHWA, RN
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (05) : S34 - S36